FDA Approves Potentially Life Saving GVOKE: Xeris’ Ready-to-Use Glucagon

Status
Not open for further replies.
Northerner

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
The FDA has approved GVOKE, a glucagon injection for the treatment of dangerously low blood sugar (severe hypoglycemia) in people with diabetes who are at least two years of age. Xeris Pharmaceutical’s GVOKE is room-temperature, liquid, stable glucagon that is ready-to-use in an emergency. It will first be launched in the US in a prefilled syringe, coming to pharmacies in October 2019. An EpiPen-like auto-injector, GVOKE HypoPen, will be launched at some point in 2020.

https://diatribe.org/fda-approves-potentially-life-saving-gvoke-xeris-ready-use-glucagon
 
Sounds good, though I wonder what preservatives it has in it to keep it useable for 2 years at room temperature.
 
The glucagon development I’ve been waiting for over the past few years is the nasal inhaler type that doesn’t need injecting.
 
I’ve never used or been given glucagon, but for sure this looks like a great development. You can’t take a fridge around with you when you’re out and about.
 
mikeyB said:
I’ve never used or been given glucagon, but for sure this looks like a great development. You can’t take a fridge around with you when you’re out and about.
Click to expand...
The current kits can be kept out of the fridge - so long as under 25c - for up to 18 months. I keep mine in my Frio wallet, as there's no point it being at home in my fridge if I'm anywhere else. But they look fiddly and daunting for family/friends to have to use in an emergency, so a ready-mixed epi-pen style thing would be much easier.
 
By and large I don’t get unmanageable emergencies these days, I must admit, because of the Libre. No surprises.
 
Status
Not open for further replies.
Back
Top